Abstract:
The present invention relates to a pharmaceutical composition or a health food comprising a Laminaria japonica extract or a porpyrin-related compound isolated therefrom which has inhibitory activity for diabetic complications. The extract shows inhibitory activity generation of aldose reductase and advanced glycation end-products and is ensured as a natural medicine; thereby can be used as a pharmaceutical composition and a food composition for preventing or treating the diabetic complications.
Abstract:
PURPOSE: A pharmaceutical composition containing an alcohol extract of Sargassum fulvellum, and an n-hexane soluble extract or a dichloromethane soluble extract is provided to suppress melanogenesis induced by alpha-MSH, and to ensure a skin whitening effect. CONSTITUTION: A cosmetic composition for skin whitening contains one or more extracts selected from an alcohol extract of Sargassum fulvellum, an n-hexane soluble extract, and a dichloromethane soluble extract. A pharmaceutical composition for treating pigmentary skin disorders contains one or more extracts selected from the alcohol extract of Sargassum fulvellum, the n-hexane soluble extract, and the dichloromethane soluble extract. Functional food for skin whitening contains one or more extracts selected from the alcohol extract of Sargassum fulvellum, the n-hexane soluble extract, and the dichloromethane soluble extract. [Reference numerals] (AA) Sargassum fulvellum; (BB) Drying in the shade; (CC) Powder; (DD) Reflux condensing extraction(Repeating 3 times); (EE) Using ethanol; (FF) Extraction; (GG) Vacuum filtration; (HH) Vacuum rotary concentration; (II) 40°C(Removing an organic solvent); (JJ) Crude extract(Ethanol extract); (KK) Organic solvent soluble fraction(Repeating 3-4 times); (LL) N-hexane soluble extract; (MM,OO) Water soluble fraction; (NN) Dichloromethane soluble extract;
Abstract:
PURPOSE: A composition containing phlorotannins derived from Ecklonia stolonifera and Ecklonia cava extract is provided to suppress iNOS and COX-2 expression and to prevent and treat inflammatory diseases. CONSTITUTION: A phlorofucofuroeckol A compound of chemical formula I is isolated from Ecklonia stolonifera and Ecklonia cava extract. A method for isolating and purifying the compound of chemical formula I comprises: a step of extracting ethanol extract of Ecklonia stolonifera and Ecklonia cava with n-hexane to prepare hexane water soluble extract; a step of extracting the hexane water soluble extract with ethyl acetate. The Ecklonia stolonifera and Ecklonia cava extract includes crude extract or non-polar solvent soluble extract. The crud extract is prepared using water, ethanol, methanol, butanol, or mixture thereof.